Today: 9 June 2026
Home Depot stock beats Wall Street selloff as investors eye the next HD earnings read
4 February 2026
1 min read

Home Depot stock beats Wall Street selloff as investors eye the next HD earnings read

New York, Feb 3, 2026, 21:11 EST — Market closed

Home Depot (HD) shares climbed roughly 0.8% to finish at $381.11 on Tuesday, bucking the wider market’s downward move. The stock fluctuated between $377.04 and $391.75 throughout the session before pulling back.

That outperformance counts as Home Depot approaches a crucial period when investors are looking for clear signals on demand, particularly for larger projects. The upcoming session might throw up mixed signals from interest rates and earnings across other sectors, but Home Depot has its own important date to watch.

Back in December, the company set a cautious tone for fiscal 2026, projecting comparable sales growth between flat and 2%, with adjusted earnings per share expected to be flat to up 4%. CFO Richard McPhail noted that so far, there’s been no sign of “a catalyst or an inflection in housing activity.” Comparable sales measure revenue from stores open at least a year, a crucial metric for retailers. Reuters

U.S. stocks slipped Tuesday as investors offloaded software and data stocks, nervous that emerging AI technologies might pressure profit margins. This came ahead of Alphabet and Amazon’s earnings reports later this week. “We’re seeing a lot of software companies across the spectrum get hit,” noted Art Hogan, chief market strategist at B. Riley Wealth. John Campbell, senior portfolio manager at Allspring Global Investments, added that “many areas, especially around AI, are priced for perfection.” The S&P 500 closed down 0.84%, while the Nasdaq fell 1.43%. Reuters

Home Depot faces recurring questions: When will big-ticket projects rebound? Are consumers favoring repairs over remodels? Changes in borrowing costs tend to influence that dynamic fast.

Management is cracking down on the corporate front. Last week, Home Depot announced plans to cut 800 jobs at its Atlanta store support center and require corporate staff to return to the office full-time, aiming for “greater agility.” Reuters

Before the bell on Wednesday, traders will be watching to see if Tuesday’s rotation gains momentum or reverses course, and how that impacts defensive and consumer-related stocks. Bond yields and housing data continue to loom large as key factors for these sectors.

The downside is straightforward. If housing activity remains weak and consumers continue postponing bigger projects, Home Depot might see another quarter with soft volumes and tougher pricing competition, squeezing margins further.

Home Depot’s fourth-quarter earnings drop on Feb. 24 at 9:00 a.m. ET stands as the next major trigger. Investors will zero in on demand trends, comparable sales figures, and whether the company adjusts its 2026 outlook.

Stock Market Today

  • Grab Shares Flat as Singapore Merchant Program and Taiwan Expansion Highlight Growth Focus
    June 9, 2026, 9:28 AM EDT. Grab Holdings' shares on Nasdaq were roughly unchanged at $3.33 in pre-market trading as the company unveiled a new food-and-beverage merchant programme in Singapore and detailed partner commitments in Taiwan. The Singapore initiative, called "Grab Full House Mission," targets smaller merchants with promotions and support to offset rising costs and softer consumer demand. In Taiwan, Grab plans a zero-cost transition and quicker onboarding for delivery partners contingent on regulatory approval of its foodpanda acquisition, marking its first expansion beyond Southeast Asia. Investors are assessing these growth strategies amid regulatory scrutiny, market incentives, and consumer spending pressures.

Latest articles

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
CoreWeave stock snaps back after lawsuit reminder and insider sale notice hit the tape
Previous Story

CoreWeave stock snaps back after lawsuit reminder and insider sale notice hit the tape

Sage Group share price slips again: AI selloff hits SGE.L ahead of AGM
Next Story

Sage Group share price slips again: AI selloff hits SGE.L ahead of AGM

Go toTop